Saxenda Market Report 2026

Saxenda Market Overview

• The Saxenda market growth in the historic period has been driven by increasing prevalence of obesity and overweight conditions, rising awareness of weight-related comorbidities • Market expansion is supported by increasing demand for long-term weight loss solutions, rising focus on metabolic health management • Growth Driver: Rising Prevalence Of Obesity Driving Market Growth Due To Increasing Demand For Weight Management Therapies • Market Trend: Innovative Generic Products Expand Affordable Alternatives For Weight Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Saxenda Market?

Saxenda is a prescription medication containing liraglutide, designed to aid in weight management for adults with obesity or overweight conditions. It works by mimicking a hormone in the body that regulates appetite, helping individuals reduce caloric intake and achieve sustained weight loss when combined with a reduced-calorie diet and increased physical activity. The main indications of saxenda include obesity management (body mass index (BMI) of ≥30 kg/m²) and overweight management (BMI of ≥27 kg/m² to <30 kg/m² with weight-related comorbidities). Obesity is characterized by a body mass index (BMI) of 30 kg/m² or higher, indicating excessive body fat accumulation. This condition significantly increases the risk of developing chronic health issues such as type 2 diabetes, hypertension, and cardiovascular diseases. The several dosage forms include injections and pre-filled pens and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies. The various end users include hospitals and clinics and homecare settings.

What Is The Saxenda Market Growth Forecast?

The growth in the forecast period can be attributed to increasing demand for long-term weight loss solutions, rising focus on metabolic health management, expansion of digital weight management programs, growing investments in obesity drug development, increasing patient adherence to injectable therapies. Major trends in the forecast period include increasing adoption of glp-1 receptor agonists, rising demand for pharmacological weight management, growing preference for injectable obesity treatments, expansion of long-term obesity care programs, enhanced focus on appetite regulation therapies.

Global Saxenda Market Segmentation

1) By Indication: Obesity Management (Body Mass Index (BMI) of ≥30 kg/m²), Overweight Management (BMI of ≥27 kg/m² to <30 kg/m² with weight-related comorbidities) 2) By Dosage Form: Injection, Pre-filled pens 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By End User: Hospitals And Clinics, Homecare Settings

What Are The Drivers Of The Saxenda Market?

The rising prevalence of obesity is expected to propel the growth of the saxenda market going forward. Obesity is a health condition marked by an excess of body fat, which raises the risk of various health issues like diabetes, heart disease, and certain cancers. The rising prevalence of obesity can be attributed to several factors, including unhealthy diets, sedentary lifestyles, urbanization, genetic factors, and hormonal imbalances. Saxenda helps combat obesity by regulating appetite through its active ingredient, liraglutide, which mimics the natural hormone GLP-1 to promote feelings of fullness, reduce caloric intake, and support sustainable weight loss when combined with a healthy diet and regular physical activity. For instance, May 2024, Office for Health Improvement & Disparities, UK-based Government department, in 2022 to 2023, approximately 64.0% of adults aged 18 and over in England were classified as overweight or obese. Therefore, the rising prevalence of obesity is driving the growth of the saxenda industry. The rising prevalence of diabetes is expected to propel the growth of the saxenda market going forward. Diabetes is a long-term condition that impacts the body's ability to regulate blood sugar (glucose) levels. The rising prevalence of diabetes is mainly due to factors such as unhealthy diets, sedentary lifestyles, obesity, aging populations, and genetic predisposition. Saxenda helps manage diabetes by leveraging its active ingredient, liraglutide, to enhance insulin sensitivity, regulate blood sugar levels, and slow gastric emptying, providing comprehensive support for glycemic control alongside its weight management benefits. For instance, in February 2023, according to a report published by Diabetes Canada, a Canada-based national charitable organization, nearly 30% of Ontario's population, or 2.4 million people, lived with diabetes or prediabetes in 2023, with a projected 25% increase in prevalence over the next decade, raising treatment costs from $1.7 billion to $2.1 billion annually by 2033. Therefore, the rising prevalence of diabetes is driving the growth of the saxenda industry.

Key Players In The Global Saxenda Market

Major companies operating in the saxenda market are Novo Nordisk

Global Saxenda Market Trends and Insights

Key companiesin the saxenda market are developing innovative products, such as generic products for weight management, to expand the availability of an affordable, approved alternative for weight management. A generic product for weight management refers to a medication that is chemically identical to a brand-name weight loss drug, providing the same therapeutic effects but marketed under its chemical name or a different brand name, typically at a lower cost. For instance, in April 2024, Biocon Limited, an India-based biopharmaceutical company, announced the approval of its generic formulation, Liraglutide (gSaxenda), by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK. This product, available as a 6 mg/ml solution in a pre-filled pen, is designed to aid in weight management when combined with a reduced-calorie diet and increased physical activity. The approval highlights the significance of cost-effective alternatives in addressing obesity, further strengthening Biocon's portfolio of vertically integrated, complex drug products.

Regional Insights

North America was the largest region in the saxenda market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Saxenda Market?

The saxenda market consists of sales of products such as prefilled pens of 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Saxenda Market Report 2026?

The saxenda market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the saxenda industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.